http://www.agios.com
Agios Pharmaceuticals, Inc. Company Intro
Industry
Healthcare
Agios Pharmaceuticals, Inc. Headquaters
88 Sidney Street
Cambridge,02139
United States
Agios Pharmaceuticals, Inc. Share price
17 May 2023 12:44 GMT
$25.70
-0.5 (-1.91 %)
Agios Pharmaceuticals, Inc. Market cap
$1.456 B
WMC RANKING
2024
Agios Pharmaceuticals, Inc. # 46
BiotechnologyLatest Agios Pharmaceuticals, Inc. News
12 Feb 2024
Transfusion-Dependent Thalassaemia Management Market Sets Sights on 6% CAGR Growth Toward 2033
The global transfusion dependent thalassaemia management market is expected to expand at a compound yearly growth rate of 6%, from US$ 10 million in 2023 to...
12 Feb 2024
Cholangiocarcinoma Therapeutics Market Charts Course for US$ 975.20 Million Horizon by 2033
The global chemotherapy-related cancer treatments market sales is expected to reach US$ 975.20 million by 2033, growing at a cumulative annual growth rate...
12 Feb 2024
Mercato della Beta Talassemia in osservazione di un'impressionante crescita durante il periodo di previsione (2023 ...
Il rapporto "Beta Thalassemia Market Insights, Epidemiology, and Market Forecast-2032" di DelveInsight offre una comprensione approfondita della Beta.
WMC Market Score
WMC Market to Revenue Score
Agios Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Agios Pharmaceuticals, Inc. | USD | $203,196 | $520,727 | $1,587,211 | $14,560B | 46 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Agios Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Agios Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Agios Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Agios Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Agios Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Agios Pharmaceuticals, Inc. | 2.21 | 18.50 | 0.09 | 0 | 0 | 0 | 6.63 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
